Insulin — At What Cost?


According to the Washington Post, small changes to existing formulas keep insulin prices high and generics out of reach — despite the fact that the original patent expired over 75 years ago. This has been an increasing financial burden to the many who are insulin-dependent and has recently caught the attention of US politicians.READ MORE

Health Insurance – Pulling Back the Veil


One Small Voice can tell data-driven stories to employers, insurers and healthcare providers. I believe more transparent conversations associated with the requirements for the appeal processes and costs for prescriptions and medical devices will allow us to create change. READ MORE